RemedyRepack Desmopressin Acetate Tablet, 0.2 mg, 100-count box recall — FDA D-0077-2023
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Complete FDA and NHTSA recall records dated in 2022, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.
Ford Motor Company (Ford) is recalling certain 2021-2022 Bronco vehicles. The right or left side impact sensors may not be properly secured to the vehicle.
General Motors, LLC (GM) is recalling certain 2022-2023 Chevrolet Malibu vehicles. The front impact bar, a structural portion of the vehicle frame, may not be properly welded to the front…
Kia America, Inc. (Kia) is recalling certain 2023 Forte vehicles. Due to a manufacturing error, the front left steering knuckle may crack, which can result in a loss of steering control.
General Motors, LLC (GM) is recalling certain 2020-2023 Cadillac CT4 and CT5; 2021-2023 Buick Envision; and 2022-2023 Cadillac Escalade and Escalade ESV, Chevrolet Silverado 1500, Suburban,…
Chrysler (FCA US, LLC) is recalling certain 2019-2022 Ram 1500, 2500, and 3500 pickup trucks. The tailgate may not latch properly due to misaligned tailgate strikers, which could result in…
Subaru of America, Inc. (Subaru) is recalling certain 2019-2022 Ascent vehicles. The ground bolt that secures the ground terminal of the Positive Temperature Coefficient (PTC) heater may…
Due to an unusual increase in the positivity rate with human IgM antibodies to cytomegalovirus (CMV) Enzyme Immunoassay (EIA).
Potential open seal pouches compromising sterility resulting in the use of a non-sterile product in surgery could lead to patient infection
The product was recalled because stability evaluation of the lots indicated a decrease in reactivity that could lead to a potential false-negative result interpretation. The issue was…
The Control Level I material value was showing results exceeding the upper limit of the acceptable range after a period of three (3) months. Additionally, per the firm, the unacceptable…
Kits containing 3M Steri-Drape Surgical Drapes recalled by 3M due to liner on the adhesive component is difficult to remove without damaging the product and may render the product unusable
Due to difficulty removing the liner on the adhesive components of the affected drapes and as a result may render the product unusable. In addition, the manufacturer of the drapes has…
Device is mislabeled. The package insert for this ASR device contains a chromomap - an image showing the position the FISH probe maps to on the specific chromosome. For this device the…
Due improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting in false positive identification results for Staphylococcus aureus and…
Distribution of COVID Test Kits without FDA Approval, Clearance or Authorization.
An error with the chromomap on version 1 of the package insert which is incorrect. The nucleotide locations specified in the insert are correct but the map has been created using the wrong…
Potential staple deployment failure and device fragment generation
The Control Level I material value was showing results exceeding the upper limit of the acceptable range after a period of three (3) months. The unacceptable Control Level 1 value results…
Stryker received a report of a battery fire involving an Airo TruCT unit previously subjected to bypass charging. The firm is notifying customers with units whose battery monitoring systems…
The product was recalled because stability evaluation of the lots indicated a decrease in reactivity that could lead to a potential false-negative result interpretation. The issue was…
Kits containing 3M Steri-Drape Surgical Drapes recalled by 3M due to liner on the adhesive component is difficult to remove without damaging the product and may render the product unusable
Due improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting in false positive identification results for Staphylococcus aureus and…
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.